Rhythm Pharmaceuticals (NASDAQ:RYTM – Get Free Report) had its target price hoisted by equities research analysts at Needham & Company LLC from $55.00 to $64.00 in a research report issued on Wednesday, Benzinga reports. The brokerage presently has a “buy” rating on the stock. Needham & Company LLC’s target price would suggest a potential upside […]